Buy Both and Save!: 2019 Clinical Nuclear Medicine & 2019 PET/CT Imaging - A Video CME Teaching Activity
AMA PRA Category 1 Credit(s)™: 20.75
Category A CE Credits:
Purchase Both and Save!!
Combined Regular Price: $1690.00
Combined Savings Price: $1415.00
CLICK BELOW TO PURCHASE
2019 Clinical Nuclear Medicine
CLICK BELOW TO PURCHASE
2019 PET/CT Imaging
CLBCTV19 CLBMRV19
About This CME Teaching Activity
This CME activity is designed to provide a practical yet in-depth review of nuclear medicine with concentration on the latest trends, protocols and advances in clinical diagnosis and patient management. Faculty discuss techniques, tips and pitfalls through didactic lectures and case-based presentations.
This CME activity provides a clinical perspective of PET and PET/CT imaging. Basic to advanced applications of PET and PET/CT are put in the context of disease detection and treatment planning. All faculty have been chosen for their teaching ability, as well as for their clinical expertise.
Target Audience
This course should benefit nuclear medicine physicians and radiologists. It should also benefit physicians who supervise and interpret nuclear medicine procedures. The course should also prove valuable for physicians who order these studies.
This CME activity should benefit radiologists, oncologists, and nuclear medicine physicians. The course should also prove valuable for physicians who order these studies.
Educational Objectives
At the completion of this CME teaching activity, you should be able to:
-
Apply state-of-the-art protocols to assess a hepatobiliary and gastrointestinal disorders.
-
Discuss current and future directions of nuclear medicine.
-
Describe the role of nuclear medicine when used to evaluate thyroid disorders.
-
Explain the expanding role of nuclear medicine studies in the detection and management of pulmonary, bone and neuroendocrine disorders.
-
Apply state-of-the-art protocols to evaluate neurodegenerative disease, head and neck and cutaneous cancers to clinical practice.
-
Optimize PET and PET/CT imaging protocols for the detection and follow up of lymphoma and musculoskeletal tumors.
-
Describe the advantages and pitfalls of PET and PET/CT.
-
Differentiate normal variants and urgent findings on PET/CT.
-
Discuss the utility of PET/CT when used to evaluate cardiac disease, gastrointestinal, thyroid and prostate cancers.
No special educational preparation is required for this CME activity.
USB & DVD Cancellation Policy: Return within 15 days of receiving - No refunds after. $125.00 processing fee for each series. Shipping non-refundable. Cancellations must be in writing. No CME credit on returned purchases. 2+ returns voids cancellation policy.
On-Demand Cancellation Policy: We offer a free trial period. Please use the evaluation period to ensure your online system meets the requirements necessary to view. If you are not satisfied, you may receive a refund within 90 days if you have watched less than 20% of your purchase.
Scientific Sponsor
Educational Symposia
Accreditation
Physicians: Educational Symposia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Educational Symposia designates this enduring material for a maximum of 10.0 AMA PRA Category 1 Credit(s)TM (2019 Clinical Nuclear Medicine) and 10.75 AMA PRA Category 1 Credit(s)TM (2019 PET/CT Imaging). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
SA-CME: Credits awarded for this enduring activity are designated "SA-CME" by the American Board of Radiology (ABR) and qualify toward fulfilling requirements for Maintenance of Certification (MOC) Part II: Lifelong Learning and Self-assessment.
All activity participants are required to take a written or online test in order to be awarded credit. (Exam materials, if ordered, will be sent with your order.) All course participants will also have the opportunity to critically evaluate the program as it relates to practice relevance and educational objectives.
AMA PRA Category 1 Credit(s)TM for these programs may be claimed until September 30, 2022.
This CME activity was planned and produced by Educational Symposia, a leader in continuing medical education since 1975.
This activity was planned and produced in accordance with the ACCME Essential Areas and Elements.
2019 Clinical Nuclear Medicine
Anca M. Avram, M.D., FACNM
Director, Nuclear Medicine Therapy Clinic
Professor of Radiology
University of Michigan Medical Center
Ann Arbor, MI
Robert M. Bober, M.D., FACC
Director of Molecular Imaging John Ochsner Heart
and Vascular Institute Ochsner Medical Center
The Ochsner Clinical School, University of Queensland
New Orleans, LA
Gagandeep Choudhary, M.D.
Assistant Professor
Division of Molecular Imaging and Therapeutics and
Neuroradiology Section
University of Alabama at Birmingham Hospital
Birmingham, AL
Joseph S. Fotos, M.D.
Assistant Professor
Penn State Health
Milton S. Hershey Medical Center
Hershey, PA
Christopher J. Palestro, M.D., FSNMMI
Professor of Radiology
Donald & Barbara Zucker School of Medicine at
Hofstra/Northwell
Chief Division of Nuclear Medicine & Molecular Imaging
Northwell Health
Manhasset & New Hyde Park, NY
Mark Tulchinsky, M.D., FACNM
Professor of Radiology and Medicine
Associate Director, Nuclear Medicine
Penn State University
Milton S. Hershey Medical Center
Hershey, PA
2019 PET/CT Imaging
Robert M. Bober, M.D., FACC
Director of Molecular Imaging John Ochsner Heart
and Vascular Institute Ochsner Medical Center
The Ochsner Clinical School, University of Queensland
New Orleans, LA
Gagandeep Choudhary, M.D.
Assistant Professor
Division of Molecular Imaging and Therapeutics and
Neuroradiology Section
University of Alabama at Birmingham Hospital
Birmingham, AL
Eric M. Rohren, M.D., Ph.D.
Professor and Chair
Department of Radiology
Baylor College of Medicine
Houston, TX
Mark Tulchinsky, M.D., FACNM
Professor of Radiology and Medicine
Associate Director, Nuclear Medicine
Penn State University
Milton S. Hershey Medical Center
Hershey, PA
Don C. Yoo, M.D., FACR
Professor, Clinical Educator
Diagnostic Imaging
Director of Nuclear Medicine, The Miriam Hospital
Director of Medical Student Radiology Education
The Warren Alpert Medical School of Brown University
Providence, RI
Katherine Zukotynski, M.D.
Associate Professor of Medicine and Radiology
McMaster University
Hamilton, ON
CANADA
2019 Clinical Nuclear Medicine
Session 1
Hepatobiliary Scintigraphy in Acute Conditions
Joseph S. Fotos, M.D.
Benign Thyroid Conditions: Imaging and Therapy (Theranostics)
Anca M. Avram, M.D., FACNM
Session 2
V/Q Imaging in Pulmonary Embolism: Planar or SPECT
Mark Tulchinsky, M.D., FACNM
Hepatobiliary Scintigraphy in Non-Acute Conditions
Joseph S. Fotos, M.D.
Gastric Emptying and Gastrointestinal Bleeding Scintigraphy
Mark Tulchinsky, M.D., FACNM
Session 3
Neuroendocrine Tumors Therapy (Theranostics)
Anca M. Avram, M.D., FACNM
Bone and Joint Scintigraphy in Benign Conditions
Christopher J. Palestro, M.D., FSNMMI
Session 4
Parathyroid Adenomas & Pheochromocytomas
Christopher J. Palestro, M.D., FSNMMI
Infection and Inflammation Scintigraphy
Christopher J. Palestro, M.D., FSNMMI
Differentiated Thyroid Cancer Therapy (Theranostics)
Anca M. Avram, M.D., FACNM
Session 5
SPECT Brain Imaging for Non-Neurodegenerative Diseases
Gagandeep Choudhary, M.D.
Myocardial Viability, Function and Innervation
Robert M. Bober, M.D., FACC
Brain Scintigraphy in Neurological Diseases
Gagandeep Choudhary, M.D.
Session 6
Myocardial Perfusion and Infarct Imaging
Robert M. Bober, MD, FACC
Lymphoscintigraphy: Radiotracers and Use of SPECT/CT
Joseph S. Fotos, M.D.
2019 PET/CT Imaging
Session 1
PET/CT Techniques and Reporting Principles
Eric M. Rohren, M.D., Ph.D.
PET/CT for Neurodegenerative Diseases
Gagandeep Choudhary, M.D.
PET/CT in Cardiology
Robert M. Bober, M.D., FACC
Session 2
PET/CT in Head and Neck Cancer
Don C. Yoo, M.D., FACR
PET/CT for Non-Neurodegenerative Diseases
Gagandeep Choudhary, M.D.
PET/CT in Thyroid Cancer
Mark Tulchinsky, M.D., FACNM
Ga-68 and Lu-177 DOTATATE in Neuroendocrine Tumors
Katherine Zukotynski, M.D.
Session 3
PET/CT in Malignancy of the Lung
Don C. Yoo, M.D., FACR
PET/CT in Malignancy of Female Breast and Pelvis
Katherine Zukotynski, M.D.
Qualitative and Quantitative Response Criteria
Eric M. Rohren, M.D., Ph.D.
Session 4
PET/CT in Infection and Inflammation Imaging
Don C. Yoo, M.D., FACR
PET/CT in Gastrointestinal Malignancies
Eric M. Rohren, M.D., Ph.D.
PET/CT in Skeletal Tumors: Primary and Metastatic
Katherine Zukotynski, M.D.
Session 5
PET/CT in Lymphomas
Mark Tulchinsky, M.D., FACNM
PET/CT in Prostate Cancer
Eric M. Rohren, M.D., Ph.D.
PET/CT in Cancers of the Skin
Mark Tulchinsky, M.D., FACNM